Richard Whitley to Drug Resistance, Viral
This is a "connection" page, showing publications Richard Whitley has written about Drug Resistance, Viral.
Connection Strength
1.484
-
Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). Clin Infect Dis. 2013 May; 56(9):1197-205.
Score: 0.446
-
Neonatal herpes simplex virus infections: where are we now? Adv Exp Med Biol. 2011; 697:221-30.
Score: 0.387
-
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza. J Infect Dis. 2013 Mar 01; 207(5):709-20.
Score: 0.111
-
Antiviral drugs and antiviral drug resistance. Curr Opin Virol. 2011 Dec; 1(6):545-7.
Score: 0.103
-
Current management and recommendations for access to antiviral therapy of herpes labialis. J Clin Virol. 2012 Jan; 53(1):6-11.
Score: 0.101
-
Therapy of herpes virus infections in children. Adv Exp Med Biol. 2008; 609:216-32.
Score: 0.079
-
The role of oseltamivir in the treatment and prevention of influenza in children. Expert Opin Drug Metab Toxicol. 2007 Oct; 3(5):755-67.
Score: 0.077
-
Current non-AIDS antiviral chemotherapy. Expert Rev Anti Infect Ther. 2007 Apr; 5(2):217-30.
Score: 0.075
-
Herpes simplex virus infection. Semin Pediatr Infect Dis. 2002 Jan; 13(1):6-11.
Score: 0.052
-
The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach. Clin Pharmacol Ther. 2014 Sep; 96(3):380-9.
Score: 0.031
-
Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides. Antimicrob Agents Chemother. 2009 Dec; 53(12):5251-8.
Score: 0.022